Results 51 to 60 of about 1,093,427 (365)

Advanced head and neck cancer: Long-term results of chemo-radiotherapy, complications and induction of second malignancies [PDF]

, 2001
Background: Chemo-radiotherapy is superior to radiotherapy alone in the treatment of advanced, inoperable head and neck cancer. The long-term treatment results, the induction of second malignant tumors, and other long-term toxicities are not well defined.
Schorer, H., Pohlmann, H., Munker, Reinhold, Aydemir, Ü., Reitmeier, M., Purmale, L., Hartenstein, R.   +6 more
core   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu, Kaitlin LaGasse, Cory D. Saucier, Kimberly Raymond, Miranda Lauher‐Charest, Lauren Crowder, Beilei Cai, Mary Lisha Paul, Denise Adams   +8 more
wiley   +1 more source

Radiotherapy and Phototherapy [PDF]

The American Journal of the Medical Sciences, 1902
n ...
openaire   +1 more source

Clinical evaluation of endolymphatic radiotherapy in malignant lymphoma

, 1974
By endolymphatic injection of radioisotope 131I.Lipiodol, so.called endolymphatic radiotherapy, we treated 10 cases with malignant lymphoma and found a marked tumor reduction to normal size in all the 10 cases we tried.
Irino, Shozo, Uno, Junichiro, Tanji, Tameyo, Oka, Akira   +3 more
core   +1 more source

Comparison of the effect of individual dietary counselling and of standard nutritional care on weight loss in patients with head and neck cancer undergoing radiotherapy. [PDF]

, 2010
Contains fulltext : 89909.pdf (Publisher’s version ) (Open Access)Clinical research shows that nutritional intervention is necessary to prevent malnutrition in head and neck cancer patients undergoing radiotherapy.
Rasmussen-Conrad, E.L., Berg, M.G. van den, Merkx, M.A.W., Kaanders, J.H.A.M., Berg, M.G.A., van den, van den Berg, M.G.A., Wei, K.H., Lintz-Luidens, H.   +7 more
core   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

The Lancet Oncology, 2020
BACKGROUND Unlike for extremity sarcomas, the efficacy of radiotherapy for retroperitoneal sarcoma is not established. The aim of this study was to evaluate the impact of preoperative radiotherapy plus surgery versus surgery alone on abdominal recurrence-
S. Bonvalot, A. Gronchi, C. Le Péchoux, C. Swallow, D. Strauss, P. Meeus, F. van Coevorden, S. Stoldt, E. Stoeckle, P. Rutkowski, M. Rastrelli, C. Raut, D. Hompes, A. De Paoli, C. Sangalli, C. Honoré, P. Chung, A. Miah, J. Blay, M. Fiore, J. Stelmes, A. D. Dei Tos, E. Baldini, S. Litière, S. Marréaud, H. Gelderblom, R. Haas   +26 more
semanticscholar   +1 more source

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.

The Lancet Oncology, 2022
BACKGROUND Patients with non-small-cell lung cancer (NSCLC) that is resistant to PD-1 and PD-L1 (PD[L]-1)-targeted therapy have poor outcomes. Studies suggest that radiotherapy could enhance antitumour immunity.
J. Schoenfeld, A. Giobbie-Hurder, S. Ranasinghe, Katrina Z Kao, Ana Lako, J. Tsuji, Yang Liu, Ryan C Brennick, R. Gentzler, Carrie Lee, J. Hubbard, S. Arnold, J. Abbruzzese, S. Jabbour, N. Uboha, K. Stephans, Jennifer M. Johnson, Haeseong Park, L. Villaruz, E. Sharon, H. Streicher, Mansoor M Ahmed, H. Lyon, Carrie Cibuskis, N. Lennon, Aashna Jhaveri, Lin Yang, Jennifer Altreuter, L. Gunasti, J. Weirather, R. Mak, M. Awad, S. Rodig, Helen X. Chen, Catherine J. Wu, A. Monjazeb, F. Hodi   +36 more
semanticscholar   +1 more source

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker, Kyle Kemp, Perri Tutelman, Sharon H. J. Hou, Paul Fairie, Maria Santana, Gregory M. T. Guilcher, Taryn Fay‐McClymont, Glenda Bendiak, Wendy Pelletier, Nicola Wright, Fiona Schulte   +11 more
wiley   +1 more source

Does setup on rectal wall improve rectal cancer boost radiotherapy?

Radiation Oncology, 2018
Background Rectal cancer patients that show a pathological complete response (pCR) after neo-adjuvant chemo-radiotherapy, have better prognosis. To increase pCR rates several studies escalate the tumor irradiation dose.
Jean-Paul J. E. Kleijnen, Bram van Asselen, Martijn Intven, Johannes P. M. Burbach, Marielle E. P. Philippens, Jan J. W. Lagendijk, Bas W. Raaymakers   +6 more
doaj   +1 more source